129 related articles for article (PubMed ID: 27025340)
81. Human 3α-hydroxysteroid dehydrogenase type 3: structural clues of 5α-DHT reverse binding and enzyme down-regulation decreasing MCF7 cell growth.
Zhang B; Hu XJ; Wang XQ; Thériault JF; Zhu DW; Shang P; Labrie F; Lin SX
Biochem J; 2016 Apr; 473(8):1037-46. PubMed ID: 26929402
[TBL] [Abstract][Full Text] [Related]
82. Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
Frotscher M; Ziegler E; Marchais-Oberwinkler S; Kruchten P; Neugebauer A; Fetzer L; Scherer C; Müller-Vieira U; Messinger J; Thole H; Hartmann RW
J Med Chem; 2008 Apr; 51(7):2158-69. PubMed ID: 18324762
[TBL] [Abstract][Full Text] [Related]
83. E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Fischer DS; Allan GM; Bubert C; Vicker N; Smith A; Tutill HJ; Purohit A; Wood L; Packham G; Mahon MF; Reed MJ; Potter BV
J Med Chem; 2005 Sep; 48(18):5749-70. PubMed ID: 16134943
[TBL] [Abstract][Full Text] [Related]
84. 17beta-Hydroxysteroid dehydrogenase inhibitors: a patent review.
Poirier D
Expert Opin Ther Pat; 2010 Sep; 20(9):1123-45. PubMed ID: 20645882
[TBL] [Abstract][Full Text] [Related]
85. New drug-like hydroxyphenylnaphthol steroidomimetics as potent and selective 17β-hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of estrogen-dependent diseases.
Marchais-Oberwinkler S; Wetzel M; Ziegler E; Kruchten P; Werth R; Henn C; Hartmann RW; Frotscher M
J Med Chem; 2011 Jan; 54(2):534-47. PubMed ID: 21189020
[TBL] [Abstract][Full Text] [Related]
86. Synthesis of simplified hybrid inhibitors of type 1 17beta-hydroxysteroid dehydrogenase via cross-metathesis and sonogashira coupling Reactions.
Bérubé M; Poirier D
Org Lett; 2004 Sep; 6(18):3127-30. PubMed ID: 15330604
[TBL] [Abstract][Full Text] [Related]
87. A sensitive pH fluorescent probe based on triethylenetetramine bearing double dansyl groups in aqueous solutions and its application in cells.
Zhou H; Feng R; Liang Q; Su X; Deng L; Yang L; Ma LJ
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Mar; 229():117881. PubMed ID: 31822453
[TBL] [Abstract][Full Text] [Related]
88. A simple and effective dansyl acid based "turn-on" fluorescent probe for detecting labile ferrous iron in physiological saline and live cells.
Gao G; Wang X; Wang Z; Jin X; Ou L; Zhou J; Xie P
Talanta; 2020 Aug; 215():120908. PubMed ID: 32312452
[TBL] [Abstract][Full Text] [Related]
89. Inactivation of the Enterobacter cloacae P99 beta-lactamase by a fluorescent phosphonate: direct detection of ligand binding at the second site.
Dryjanski M; Pratt RF
Biochemistry; 1995 Mar; 34(11):3569-75. PubMed ID: 7893653
[TBL] [Abstract][Full Text] [Related]
90. Synthesis and application of a fluorescent imido ester for specific labelling of amino groups in proteins.
Bozler H; Jany KD; Pfleiderer G
Biochim Biophys Acta; 1983 Dec; 749(3):238-43. PubMed ID: 6419775
[TBL] [Abstract][Full Text] [Related]
91. Currently available murine Leydig cell lines can be applied to study early steps of steroidogenesis but not testosterone synthesis.
Engeli RT; Fürstenberger C; Kratschmar DV; Odermatt A
Heliyon; 2018 Feb; 4(2):e00527. PubMed ID: 29560447
[TBL] [Abstract][Full Text] [Related]
92. Synthesis of a human urate transporter-1 inhibitor, an arginine vasopressin antagonist, and a 17β-hydroxysteroid dehydrogenase type-3 inhibitor, using ring-expansion of cyclic ketoximes with DIBALH.
Cho H; Iwama Y; Okano K; Tokuyama H
Chem Pharm Bull (Tokyo); 2014; 62(4):354-63. PubMed ID: 24695345
[TBL] [Abstract][Full Text] [Related]
93. Synthesis of fluorescent substrates for protein tyrosine phosphatase assays.
Watanabe T; Imoto M; Taniguchi H; Kinoshita K; Umezawa K
Bioorg Med Chem Lett; 1998 Jun; 8(11):1301-2. PubMed ID: 9871754
[TBL] [Abstract][Full Text] [Related]
94. Synthesis, characterization and fluorescence studies on N-alpha-dansylalanyllysyl trypsino (HIS-46)-methane.
Penny GS; Dyckes DF; Burleigh BD
Int J Pept Protein Res; 1979 Jan; 13(1):95-101. PubMed ID: 422327
[TBL] [Abstract][Full Text] [Related]
95. The design of fluorescent probes which bind to the active centre of guanidinobenzoatase. Application to the location of cells possessing this enzyme.
Steven FS; Griffin MM; Al-Ahmad RK
Eur J Biochem; 1985 May; 149(1):35-40. PubMed ID: 2581779
[TBL] [Abstract][Full Text] [Related]
96. Tumor cell proteinase visualization and quantification using a fluorescent transition-state analog probe.
Kozlowski KA; Wezeman FH; Schultz RM
Proc Natl Acad Sci U S A; 1984 Feb; 81(4):1135-9. PubMed ID: 6366797
[TBL] [Abstract][Full Text] [Related]
97. Combinatorial Dansyl Library and its Applications to pH-Responsive Probes.
Hong SC; Murale DP; Lee JS
Comb Chem High Throughput Screen; 2016; 19(5):347-52. PubMed ID: 27055754
[TBL] [Abstract][Full Text] [Related]
98. Design of fluorescent probes for an enzyme on the surface of tumour cells.
Steven FS; Griffin MM; Al-Ahmad RK
J Chromatogr; 1986 Apr; 376():211-9. PubMed ID: 3711193
[TBL] [Abstract][Full Text] [Related]
99. Synthesis and fluorescence properties of a probe for membrane anionic sites.
Narayanan R; Balaram P
Biochem Biophys Res Commun; 1976 Jun; 70(4):1122-8. PubMed ID: 942433
[No Abstract] [Full Text] [Related]
100. [The function of 17beta-hydroxysteroid dehydrogenase family].
Su W; Xu HM; Kang JH
Sheng Li Ke Xue Jin Zhan; 2014 Feb; 45(1):27-31. PubMed ID: 24873140
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
